Polypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40L
US-12509522-B2 · Dec 30, 2025 · US
Park John is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Park John |
| Total patents | 12 |
| First publication | Jun 24, 2021 |
| Latest publication | Dec 30, 2025 |
Publications ranked by popularity score, then publication date.
US-12509522-B2 · Dec 30, 2025 · US
US-12492248-B2 · Dec 9, 2025 · US
US-12384840-B2 · Aug 12, 2025 · US
US-2024076689-A1 · Mar 7, 2024 · US
US-11840566-B2 · Dec 12, 2023 · US
US-2022177566-A1 · Jun 9, 2022 · US
US-2022177565-A1 · Jun 9, 2022 · US
US-2022177564-A1 · Jun 9, 2022 · US
US-2022153854-A1 · May 19, 2022 · US
US-11208476-B2 · Dec 28, 2021 · US
Latest publications not already listed above.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ablynx Nv | 11 |
| Sanofi Sa | 11 |
| Boehringer Ingelheim Int | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/94 | 11 |
| C07K2317/31 | 11 |
| C07K16/244 | 11 |
| C07K2317/76 | 11 |
| C07K16/18 | 11 |